Article Figures & Data
Figures
Figure 1. Histologic and immunohistochemical analysis of remnant kidneys in the early phase. Periodic acid-Schiff (PAS) and Trichrome Masson staining of normal kidneys (sham group) showed no evidence of tubulointerstitial damage (a and b). PAS and Trichrome Masson staining of the early phase of remnant kidneys (7d RK) (e and f) also showed no interstitial damage. Double-staining with perfused lectin (brown) and vimentin (black) showed that expression of vimentin in tubules could not be detected in either sham (c) or 7d RK (g). Immunohistochemical studies of α-smooth muscle actin (α-SMA) showed lack of interstitial myofibroblasts in sham (d) and 7d RK (h).
Figure 2. Increased pimonidazole uptake by remnant kidneys in the early phase. Double immunohistochemical staining with perfused lectin (brown) and a hypoxic probe, pimonidazole (gray) (×200). (a) No pimonidazole uptake was observed in the renal cortex in the sham group, while tubules in the deep medulla were pimonidazole-positive. (b) In the early phase after nephron loss (4 and 7 d), many tubules in the cortex showed pimonidazole uptake, indicating that these tubules were in a hypoxic condition. Treatment with an ARB, olmesartan, decreased pimonidazole uptake in the cortex of remnant kidneys at both time points (4 and 7 d), indicating that hypoxia of the tubulointerstitium may be mediated at least in part by activation of RAS. (c) In the extended phase (2 wk) of RK, rats showed sustained adduction of pimonidazole. (d) A high-magnification picture (×400) of sham animals showed the normal structure of perfused postglomerular capillary networks surrounded by tubules negative for pimonidazole. (e) In contrast, a high-magnification picture of the RK group showed pimonidazole adduction, indicating localized hypoxia.
Figure 3. Upregulation of hypoxia-responsive proteins in remnant kidneys. (a) Imunoprecipitation of HIF-1α using cortical tissues of sham and remnant kidney rats. HIF-1α was undetectable in sham kidneys, but was increased in remnant kidneys. (b) Transcription of hypoxia-responsive genes. Quantitative RT-PCR of the renal cortex of sham and remnant kidneys showed that all genes, including EPO, GLUT-1, and VEGF, were increased in remnant kidneys. Olmesartan-treated animals showed a decrease in all hypoxia-responsive genes. A, P < 0.05 versus sham; B, P < 0.05 versus RK.
Figure 4. Change in pattern of postglomerular peritubular capillaries in remnant kidneys. Immunohistochemical studies were conducted on binding of injected lectin to endothelial cells of functioning capillaries. (a) In sham-operated animals, peritubular capillaries were arranged in a regular pattern with patent capillary lumina. (b) In early remnant kidneys (RK) (representative picture from 4d RK), most capillary lumina were distorted and had relatively narrow lumens. (c) ARB treatment restored the normal capillary morphology (representative picture from 7d RK+ARB). (d) Histogram of luminal area demonstrated that remnant kidneys harbored more narrow peritubular capillaries. Treatment with ARB prevented this change. (e) Correlation between mean capillary luminal area and pimonidazole score in each animal showed that narrowing of capillaries correlated with hypoxia.
Figure 5. Tissue perfusion studies with Hoechest 33342 dye. Tissue perfusion status was assessed by injection of Hoechest 33342 dye exactly 30 s before removal of the kidney. In sham animals, nuclear fluorescence was intense in every area (a), whereas nuclear fluorescence signals in the RK group were distinctly decreased in the tubulointerstitial area (b). Treatment with ARB increased nuclear fluorescence (c), indicating that ARB restored net perfusion in remnant kidneys. Semiquantitative measurement of nuclear luminosity supported these results (Table 3).
Figure 6. Hypoxia-induced endothelial proliferation. Double-staining with lectin (brown) and proliferative cell nuclear antigen (PCNA) (red) showed that endothelial proliferation was increased in remnant kidneys around day 7. (a) In sham animals, endothelial proliferation was rarely detected. (b) PCNA-positive endothelial cells were markedly increased in the 7d RK group. (c and f) ARB treatment decreased PCNA-positive endothelial cells at this time point. (d and e) Triple staining with lectin (brown), PCNA (red), and pimonidazole (gray) of 7d RK animals showed that endothelial proliferation in remnant kidneys was related to hypoxia and capillary pattern changes (representative pictures were taken from the same slide). In the hypoxic area of RK rats, tubules were pimonidazole-positive with distorted peritubular capillaries and expression of PCNA in capillary endothelium (e), while PCNA-positive endothelial cells were rarely seen in the nonhypoxic area, and tubules were accompanied by capillaries with preserved morphology. (g) The percentage of PCNA-positive endothelial cells per capillary lumina in nonhypoxic areas (pimonidazole score 0 or 1) was significantly lower than that in hypoxic areas (pimonidazole score >1). A, P < 0.05 versus sham; B, P < 0.05 versus RK; C, P < 0.05
Tables
Table 1. Basic biological data
Sham 4d RK 4d RK + ARB 7d RK 7d RK + ARB Extended RK a P < 0.05 versus sham. b P < 0.05 versus matched time point RK (ANOVA). Systolic BP (mmHg) 118 ± 6.3 146 ± 5.9a 113 ± 5.9b 166 ± 9.2a 128 ± 7.5b 187 ± 4.9a Diastolic BP (mmHg) 79 ± 12.9 105 ± 10.7a 80 ± 12.4b 120 ± 3.6a 90 ± 15b 127 ± 3.8a Blood urea nitrogen (mg/dl) 16.1 ± 1.2 32.8 ± 9.1a 27.6 ± 10.1a 36.5 ± 11.7a 31.7 ± 5.4a 62.5 ± 6.7a 24-h urine protein (mg) 8.2 ± 0.5 34.2 ± 8.7a 20.3 ± 3.7ab 51.5 ± 8.6a 20.3 ± 4.5ab 86.5 ± 8a Table 2. Semiquantitative scores of histological analysis
Sham 4d RK 4d RK + ARB 7d RK 7d RK + ARB Extended RK a P < 0.05 versus sham. b P < 0.05 versus matched time point RK (Mann-Whitney U test). PAS Tubular atrophy 0.3 ± 0.1 0.3 ± 0.2 0.3 ± 0.2 0.4 ± 0.1 0.4 ± 0.1 0.9 ± 0.2a Interstitial infiltration 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 1.0 ± 0.1a Trichrome Masson Interstitial expansion 0.1 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 1.3 ± 0.2a Pimonidazole adduction 0.6 ± 0.2 2.6 ± 0.4a 0.9 ± 0.3b 3.1 ± 0.3a 1.4 ± 0.6b 3.0 ± 0.2a Vimentin 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 0.4 ± 0.1a α-SMA 0 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 0.2 ± 0.1 Table 3. Analysis of the vasculature in the early phase
Sham 4d RK 4d RK + ARB 7d RK 7d RK + ARB a P < 0.05 versus sham. b P < 0.05 versus matched time point RK (ANOVA). Capillary lumina/100 tubules 187.3 ± 8.9 180.9 ± 16.9 181.9 ± 11.1 180.2 ± 12.5 188.8 ± 15.9 Capillary rarefaction index (%) 1.1 ± 0.8 2.3 ± 1.5 1.1 ± 1.1 2.8 ± 1.2 2.8 ± 1.8 Luminal area (microns2) 84.2 ± 0.6 63.3 ± 7.5a 73.7 ± 7.6ab 57.7 ± 8.4a 73.5 ± 5.7ab Nuclear fluorescent signal density 121.9 ± 4.3 88.8 ± 3.7a 106.5 ± 8.9ab 82.5 ± 5.2a 104.3 ± 10.5ab